Slovenia’s role in the global pharmaceutical supply chain
Céline joined swissinfo.ch in 2018 as video journalist for the 'Nouvo in English' project, just after graduating from the Academie du journalisme et des medias (AJM) at the University of Neuchâtel. Originally from Ticino, she's been filming, writing and interviewing people all over Switzerland since she got her first reporter badge at 11 during a school camp.
Jessica covers the good, the bad, and the ugly when it comes to big global companies and their impact in Switzerland and abroad. She’s always looking for a Swiss connection with her native San Francisco and will happily discuss why her hometown has produced some of the greatest innovations but can’t seem to solve its housing crisis.
-
DeutschdeDie Schweiz wird immer abhängiger von der slowenischen PharmaindustrieRead more: Die Schweiz wird immer abhängiger von der slowenischen Pharmaindustrie
-
PortuguêsptO papel da Eslovênia na cadeia de suprimentos farmacêutica globalRead more: O papel da Eslovênia na cadeia de suprimentos farmacêutica global
-
РусскийruРоль Словении в глобальной цепи поставок фармацевтической продукцииRead more: Роль Словении в глобальной цепи поставок фармацевтической продукции
Switzerland’s becoming increasingly dependent on Slovenia’s pharmaceutical industries. For decades, Novartis and Sandoz have been investing large sums of money into the Balkan nation, turning into a key partner for development and manufacturing of both innovative and copycat drugs.
More
Swiss pharma’s big bet on Slovenia
Edited by Nerys Avery and Marius Grieder.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.